Frozen Shoulder (Scapular Mobilization Versus Scapular PNF)
SCAPULAR MOBILIZATION VERSUS SCAPULAR PROPRIOCEPTIVE NEURO MUSCULAR FACILITATION ON FROZEN SHOUDER
1 other identifier
interventional
42
1 country
1
Brief Summary
This study will be conducted to examine and compare the effects of SM versus SPNF on shoulder pain, ROM and functional disabilities in patients with frozen shoulder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2023
CompletedStudy Start
First participant enrolled
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJuly 3, 2024
July 1, 2024
9 months
December 29, 2023
July 2, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Shoulder disability
Shoulder Pain and Disability Index (SPADI) The translated version of SPADI in the Arabic language showed excellent internal consistency and test-retest reliability. Validity was shown by substantial correlations between SPADI and Quick DASH, NRS, and active shoulder ROM. The Arabic SPADI is recommended for the evaluation of patients with shoulder dysfunction
4 weeks
Shoulder range of motion
A goniometer is a device used to measure the range of motion (in degrees) of joints for either active or passive range. Shoulder flexion, extension, abduction adduction, internal rotation and external rotation will be assessed by Goniometer
4 weeks
Secondary Outcomes (2)
Scapular upward rotation
4 weeks
Lateral scapular slide test
4 weeks
Study Arms (2)
group A
EXPERIMENTALGroup A (n = 21): will receive scapular mobilization combined with mobilization with movement (MWM) and capsular stretch for 4 weeks. Mulligan Mobilization with Movement for peripheral joints combines sustained manual application of 'gliding' force to a joint, with the aim of repositioning the positional faults with concurrent physiological motion of the joint, either performed actively by the subject or passively by the therapist
group B
EXPERIMENTALGroup B (n = 21): will receive scapular proprioceptive neuromuscular facilitation combined with (MWM) and capsular stretch for 4 weeks. Scapular PNF incorporates functional or diagonal patterns (anterior elevation - posterior depression and posterior elevation - anterior depression) for performing the exercises and can be used to stretch or strengthen the muscles selectively. These techniques help the muscles to relearn the normal timing of recruitment and the amount of activation to sustain the balance between different groups of muscles
Interventions
Two treatment groups will receive interventions as follows: Group A (n = 21): will receive scapular mobilization combined with mobilization with movement (MWM) and capsular stretch for 4 weeks. Group B (n = 21): will receive scapular proprioceptive neuromuscular facilitation combined with (MWM) and capsular stretch for 4 weeks.
Eligibility Criteria
You may qualify if:
- \- All the patients refferd from orthopaedic surgeon with diagnosis of adhesive capsulitis. Patients will be included in this study if they fulfil the following criteria
- Case diagnosed with adhesive capsulitis, both primary and secondary.
- Both males and females of the age group 40 to 60 years.
- Limited active and passive movement of the shoulder joint movements, as well as difficulties with ADLs.
- The onset of symptoms between 3 to 12 months. 5. Unilateral adhesive capsulitis.
You may not qualify if:
- \. History of shoulder surgery or manipulation under anaesthesia, local corticosteroid injection administration to the affected shoulder within the last 6 months, 2. Neurological deficit affecting the shoulder function during daily activities, 3. Pathology of the shoulder joint other than adhesive capsulitis including rotator cuff tear, tendonitis at the shoulder and neck region, malignancies, history of trauma or accidental injuries of the upper limb.
- Other pathological conditions including, a history of stroke, history of mastectomy and coronary artery bypass grafting (CABG).
- \. Rheumatoid arthritis, osteoporosis, or disorders of the cervical spine, elbow, wrist or hand.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, 02, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mona M ibrahim
Cairo University
- STUDY DIRECTOR
mahmoud alsehemy
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- triple-blinded clinical randomized trial
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
December 29, 2023
First Posted
January 11, 2024
Study Start
January 10, 2024
Primary Completion
October 10, 2024
Study Completion
December 1, 2024
Last Updated
July 3, 2024
Record last verified: 2024-07